1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62(1): 10-29. doi: 10.3322/caac.20138
2. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 1997; 15(6): 2403-2413. doi: 10.1200/jco.1997.15.6.2403
3. Berlin J and Benson AB, 3rd. Chemotherapy: gemcitabine remains the standard of care for pancreatic cancer. Nat Rev Clin Oncol. 2010; 7(3): 135-137. doi: 10.1038/nrclinonc.2010.16
4. Korc M. Pancreatic cancer-associated stroma production. Am J Surg. 2007; 194(4 Suppl): S84-S86. doi: 10.1016/j.amjsurg.2007.05.004
5. Marks E, Saif MW and Jia Y. Updates on first-line therapy for metastatic pancreatic adenocarcinoma. JOP: Journal of the pancreas. 2014; 15(2): 99-102. doi: 10.6092/1590-8577/2279
6. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. The New England Journal of Medicine. 2011; 364(19): 1817-1825. doi: 10.1056/NEJMoa1011923
7. Crawford HC, Dempsey PJ, Brown G, Adam L, Moss ML. ADAM10 as a therapeutic target for cancer and inflammation. Current Pharmaceutical Design. 2009; 15(20): 2288-2299. doi: 10.2174/138161209788682442
8. Moss ML, Stoeck A, Yan W, Dempsey PJ. ADAM10 as a target for anti-cancer therapy. Current Pharmaceutical Biotechnology. 2008; 9(1): 2-8. doi: 10.2174/138920108783497613
9. Seals DF and Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003; 17(1): 7-30. doi: 10.1101/gad.1039703
10. Nakamura H, Suenaga N, Taniwaki K, et al. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase. Cancer Research. 2004; 64(3): 876-882. doi: 10.1158/0008-5472.CAN-03-3502
11. Reiss K, Maretzky T, Ludwig A, et al. ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. The EMBO journal. 2005; 24(4): 742-752. doi: 10.1038/sj.emboj.7600548
12. Maretzky T, Reiss K, Ludwig A, et al. ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proceedings of the National Academy of Sciences of the United States of America. 2005; 102(26): 9182-9187. doi: 10.1073/pnas.0500918102
13. Woods NK, Padmanabhan J. Inhibition of amyloid precursor protein processing enhances gemcitabine-mediated cytotoxicity in pancreatic cancer cells. The Journal of Biological Chemistry. 2013. doi: 10.1074/jbc.M113.459255
14. Gaida MM, Haag N, Gunther F, et al. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma. Int J Mol Med. 2010; 26(2): 281-288. doi: 10.3892/ijmm_00000463
15. Sebens Muerkoster S, Werbing V, et al. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene. 2007; 26(19): 2759-2768. doi: 10.1038/sj.onc.1210076
16. Wente MN, Gaida MM, Mayer C, et al. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma. Int J Oncol. 2008; 33(2): 297-308. doi: 10.3892/ijo_00000009
17. Ringel J, Rychly J, Nebe B, et al. CD44, bFGF and hyaluronan in human pancreatic cancer cell lines. Annals of the New York Academy of Sciences. 1999; 880: 238-242. doi: 10.1111/j.1749-6632.1999.tb09528.x
18. Woods N, Trevino J, Coppola D, Chellappan S, Yang S, Padmanabhan J. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and beta-catenin signaling. Oncotarget. 2015; 6(34): 35931-35948. doi: 10.18632%2Foncotarget.5933
19. Wojtalewicz N, Sadeqzadeh E, Weiss JV, et al. A soluble form of the giant cadherin Fat1 is released from pancreatic cancer cells by ADAM10 mediated ectodomain shedding. PLoS One. 2014; 9(3): e90461. doi: 10.1371/journal.pone.0090461
20. Sing A, Tsatskis Y, Fabian L, et al. The atypical cadherin fat directly regulates mitochondrial function and metabolic state. Cell. 2014; 158(6): 1293-1308. doi: 10.1016/j.cell.2014.07.036
21. Tanoue T, Takeichi M. Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. The Journal of Cell Biology. 2004; 165(4): 517-528. doi: 10.1083/jcb.200403006